Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 2395-2406, July 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohnuma, T.
Right arrow Articles by Holland, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohnuma, T.
Right arrow Articles by Holland, J. F.

Nutritional Consequences of Cancer Chemotherapy and Immunotherapy1

Takao Ohnuma2 and James F. Holland

Department of Neoplastic Diseases, Mount Sinai School of Medicine, New York, New York 10029

The nutritional consequences of major cancer chemotherapeutic and immunotherapeutic agents are reviewed. In addition, nutritional approaches to cancer treatment are discussed. Effects on host nutrition are related to two primary drug functions, i.e., biochemical interaction with the target tissues and pharmacological action on the host. Treatments with these agents result in profound effects on the gastrointestinal, central nervous, cardiopulmonary, renal, musculoskeletal, hematopoietic, and constitutional systems of cancer patients who have already been nutritionally compromised.

Prevention and treatment of the nutritional consequences of chemotherapy and immunotherapy include specific treatment against particular agents and nonspecific symptomatic or supportive therapy. A modern concept of parenteral nutrition combined with chemotherapy and immunotherapy is one example of a nonspecific approach with a high promise for general use.

More importantly, increasing success in the long-term control of leukemia, Hodgkin's disease, and certain other neoplasms has interrupted the vicious cycle promulgated on the host nutrition by neoplasia and toxic agents. New concepts of chemotherapy, e.g., short intensive treatment instead of prolonged treatment, and surgical adjuvant treatment instead of therapy of patients with advanced cancer, have minimized the nutritional consequences of chemotherapeutic and immunotherapeutic agents.

1 Presented at the Conference on Nutrition and Cancer Therapy, November 29 to December 1, 1976, Key Biscayne, Fla. Supported in part by USPHS Grant 5 POI CA15936-03 from the National Cancer Institute, Department of Health, Education and Welfare.

2 Presenter.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.